IMPACT THERAP-B (07630) has been included in the Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect securities list.

IMPACT THERAP-B (07630) announced that, according to the announcements issued by the Shanghai Stock Exchange and the Shenzhen Stock Exchange, the company's H shares have been included in the list of eligible securities for the Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect, effective from September 7, 2026. Once the company's H shares are included in the list of eligible securities for the Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect, qualified investors in mainland China will be able to directly invest in the company's H shares through the Shanghai Stock Exchange and Shenzhen Stock Exchange. The company believes that inclusion in the Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect will help further expand the company's investor base and is expected to enhance the liquidity of the company's H shares.